Human Resources Contracts & Agreements in the Biotechnology Industry

14,605 Contracts & Agreements

Browse by Subcategory

Bonus & Incentive Agreements (4,724 contracts from 596 companies)
Change of Control Agreements (492 | 138)
Compensation Agreements (1,251 | 353)
Confidentiality Agreements (40 | 15)
Consulting Agreements (1,038 | 365)
Employment Agreements (5,516 | 580)
Non-Competition Agreements (50 | 31)
Retention Agreements (132 | 52)
Retirement Agreements (52 | 23)
Separation Agreements (761 | 329)
Severance Agreements (425 | 117)
Transition Agreements (124 | 80)

Browse by Company

2seventy bio, Inc. (15 contracts)
4D Molecular Therapeutics Inc (17)
89bio, Inc. (14)
AbbVie Inc. (26)
ABEONA THERAPEUTICS INC. (8)
ACADIA PHARMACEUTICALS INC (26)
ACCELERON PHARMA INC (34)
Accustem Sciences Inc. (4)
Achaogen, Inc. (23)
ACHIEVE LIFE SCIENCES, INC. (22)
Acorda Therapeutics (28)
Actinium Pharmaceuticals, Inc. (17)
Acumen Pharmaceuticals, Inc. (12)
Acurx Pharmaceuticals, LLC (4)
Adagio Therapeutics, Inc. (33)
Adamas Pharmaceuticals Inc (24)
Adaptimmune Therapeutics PLC (15)
Adhera Therapeutics, Inc. (29)
ADiTx Therapeutics, Inc. (16)
ADMA BIOLOGICS, INC. (18)
ADURO BIOTECH, INC. (41)
Advaxis, Inc. (17)
Adverum Biotechnologies, Inc. (76)
Aeglea BioTherapeutics, Inc. (29)
Aerovate Therapeutics, Inc. (9)
AGENUS INC (52)
AgeX Therapeutics, Inc. (7)
AGIOS PHARMACEUTICALS INC (19)
AILERON THERAPEUTICS INC (30)
Aimmune Therapeutics, Inc. (20)
AKCEA THERAPEUTICS, INC. (28)
Akebia Therapeutics, Inc. (53)
Akero Therapeutics, Inc. (7)
Akouos, Inc. (7)
ALBIREO PHARMA, INC. (65)
Aldeyra Therapeutics, Inc. (13)
Alector, Inc. (13)
Alexion Pharmaceuticals (60)
Aligos Therapeutics, Inc. (21)
Alkermes plc. (57)
Allakos Inc. (17)
Allarity Therapeutics, Inc. (9)
Allena Pharmaceuticals, Inc. (14)
Alliqua BioMedical, Inc. (41)
Allogene Therapeutics, Inc. (20)
Allovir, Inc. (13)
ALNYLAM PHARMACEUTICALS, INC. (47)
Alpha Healthcare Acquisition Corp. (18)
ALPINE IMMUNE SCIENCES, INC. (46)
Altimmune, Inc. (44)
ALX ONCOLOGY HOLDINGS INC (7)
Alzamend Neuro, Inc. (2)
AMARILLO BIOSCIENCES INC (18)
AMARIN CORP PLC (30)
AMERICAN CRYOSTEM Corp (2)
Amgen Inc. (123)
AMICUS THERAPEUTICS, INC. (67)
AmpliPhi Biosciences Corp (19)
Amplitude Healthcare Acquisition Corp (14)
ANAPTYSBIO INC (23)
ANAVEX LIFE SCIENCES CORP. (18)
Anchiano Therapeutics Ltd. (7)
Anika Therapeutics (41)
Anixa Biosciences Inc (5)
Annexon, Inc. (21)
Annovis Bio, Inc. (8)
Apellis Pharmaceuticals, Inc. (15)
APPLIED GENETIC TECHNOLOGIES CORP (22)
Applied Molecular Transport Inc. (20)
Applied Therapeutics Inc. (15)
Aprea Therapeutics, Inc. (17)
Aptevo Therapeutics Inc. (10)
Aptinyx Inc. (5)
Aptose Biosciences Inc. (8)
AquaBounty Technologies, Inc. (8)
AQUINOX PHARMACEUTICALS, INC (35)
Aravive, Inc. (22)
Arbutus Biopharma Corp (49)
ARCA biopharma, Inc. (32)
Arcellx, Inc. (12)
Arcturus Therapeutics Holdings Inc. (2)
Arcus Biosciences, Inc. (18)
Arcutis Biotherapeutics, Inc. (19)
ARDELYX, INC. (36)
ARENA PHARMACEUTICALS INC (91)
ARROWHEAD PHARMACEUTICALS, INC. (13)
Arsanis, Inc. (45)
Artiva Biotherapeutics, Inc. (16)
ARYA Sciences Acquisition Corp II (26)
ASSEMBLY BIOSCIENCES, INC. (48)
Atara Biotherapeutics, Inc. (28)
Athenex, Inc. (15)
ATHERSYS, INC (37)
ATOSSA GENETICS INC (19)
Atreca, Inc. (26)
aTYR PHARMA INC (18)
Aura Biosciences, Inc. (12)
Aurinia Pharmaceuticals Inc. (15)
AVEO PHARMACEUTICALS INC (36)
Avid Bioservices, Inc. (29)
Avidity Biosciences, Inc. (18)
Avita Therapeutics, Inc. (16)
AVROBIO, Inc. (30)
Axcella Health Inc. (24)
Axovant Sciences Ltd. (22)
Ayala Pharmaceuticals, Inc. (6)
AZIYO BIOLOGICS, INC. (14)
AzurRx BioPharma, Inc. (7)
BCTG Acquisition Corp. (7)
Beam Therapeutics Inc. (17)
BeiGene, Ltd. (70)
BELLICUM PHARMACEUTICALS, INC (58)
Benitec Biopharma Inc. (5)
BICYCLE THERAPEUTICS Ltd (22)
Big Cypress Acquisition Corp. (10)
BIO-PATH HOLDINGS INC (21)
bioAffinity Technologies, Inc. (10)
BioAtla, Inc. (10)
BioCardia, Inc. (11)
BIOCEPT INC (20)
BIOCRYST PHARMACEUTICALS INC (24)
Biogen Inc. (61)
Biohaven Pharmaceutical Holding Co Ltd. (17)
BioLife4D Corp (3)
BIOMARIN PHARMACEUTICAL INC (77)
Biomea Fusion, Inc. (14)
BioNexus Gene Lab Coporation (5)
BioRestorative Therapies, Inc. (25)
BIOSPECIFICS TECHNOLOGIES CORP (19)
Biostage, Inc. (29)
BIOTIME INC (37)
BIOVIE INC. (8)
BioXcel Therapeutics, Inc. (28)
BIOXYTRAN, INC (7)
Bison Capital Acquisition Corp. (1)
Black Diamond Therapeutics, Inc. (18)
Blue Water Vaccines Inc. (30)
bluebird bio, Inc. (29)
Blueprint Medicines Corp (61)
Bolt Biotherapeutics, Inc. (10)
Bone Biologics Corp (10)
BRAINSTORM CELL THERAPEUTICS INC. (38)
BriaCell Therapeutics Corp. (5)
BridgeBio Pharma, Inc. (11)
BullFrog AI Holdings, Inc. (3)
BURZYNSKI RESEARCH INSTITUTE INC (1)
C4 Therapeutics, Inc. (6)
Cabaletta Bio, Inc. (13)
CALADRIUS BIOSCIENCES, INC. (38)
Calithera Biosciences, Inc. (12)
Calyxt, Inc. (46)
CANCER GENETICS, INC (29)
Candel Therapeutics, Inc. (14)
CAPRICOR THERAPEUTICS, INC. (22)
CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. (6)
Capstone Therapeutics Corp. (18)
CareDx, Inc. (27)
Caribou Biosciences, Inc. (47)
CASI Pharmaceuticals, Inc. (27)
CASTLE BIOSCIENCES INC (22)
Castle Creek Biosciences, Inc. (6)
CATABASIS PHARMACEUTICALS INC (17)
CATALYST BIOSCIENCES, INC. (84)
CATALYST PHARMACEUTICALS, INC. (23)
CEL SCI CORP (6)
Celcuity Inc. (12)
Cell Source, Inc. (3)
Celldex Therapeutics, Inc. (51)
Cellectar Biosciences, Inc. (32)
Cellular Biomedicine Group, Inc. (20)
Celsion CORP (32)
Centessa Pharmaceuticals Ltd (9)
Century Therapeutics, Inc. (16)
CEREBAIN BIOTECH CORP. (7)
Chanticleer Holdings, Inc. (8)
Chardan Healthcare Acquisition 2 Corp. (11)
Chardan Healthcare Acquisition Corp. (1)
Checkmate Pharmaceuticals, Inc. (8)
Checkpoint Therapeutics, Inc. (10)
Chelsea Worldwide Inc. (7)
ChemoCentryx, Inc. (25)
CHIMERIX INC (23)
Cibus Global, Ltd. (5)
Cidara Therapeutics, Inc. (17)
CLEVELAND BIOLABS INC (25)
Clovis Oncology, Inc. (15)
CM Life Sciences III Inc. (6)
Codiak BioSciences, Inc. (11)
CohBar, Inc. (18)
Coherus BioSciences, Inc. (12)
Comera Life Sciences Holdings, Inc. (4)
COMPASS Pathways plc (8)
Conatus Pharmaceuticals Inc. (42)
CONCERT PHARMACEUTICALS, INC. (17)
Consonance-HFW Acquisition Corp. (5)
Constellation Alpha Capital Corp. (24)
CONSTELLATION PHARMACEUTICALS INC (10)
CONTRAFECT Corp (27)
Corbus Pharmaceuticals Holdings, Inc. (32)
Cortexyme, Inc. (27)
Corvus Pharmaceuticals, Inc. (8)
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (2)
Crinetics Pharmaceuticals, Inc. (19)
CRISPR Therapeutics AG (26)
CTD HOLDINGS INC (13)
CTI BIOPHARMA CORP (71)
Cue Biopharma, Inc. (24)
Cullinan Oncology, LLC (15)
Curative Biotechnology Inc (21)
CURIS INC (53)
Cyclacel Pharmaceuticals, Inc. (32)
Cyclerion Therapeutics, Inc. (13)
CytoDyn Inc. (48)
Cytokinetics, Incorporated (26)
CytomX Therapeutics, Inc. (40)
CYTORI THERAPEUTICS, INC. (28)
CYTRX CORP (65)
Day One Biopharmaceuticals Holding Co LLC (4)
DBV Technologies S.A. (1)
Decibel Therapeutics, Inc. (21)
DECIPHER BIOSCIENCES, INC. (2)
Deciphera Pharmaceuticals, Inc. (32)
DelMar Pharmaceuticals, Inc. (24)
Denali Therapeutics Inc. (8)
Dermavant Sciences Ltd (8)
Dermira, Inc. (8)
Design Therapeutics, Inc. (14)
DiaMedica Therapeutics Inc. (18)
Dicerna Pharmaceuticals Inc (38)
Diffusion Pharmaceuticals Inc. (46)
Digital Development Partners, Inc. (1)
DYADIC INTERNATIONAL INC (9)
Dynamics Special Purpose Corp. (8)
DYNAVAX TECHNOLOGIES CORP (30)
Dyne Therapeutics, Inc. (18)
Eagle Pharmaceuticals, Inc. (19)
Edge Therapeutics, Inc. (36)
Editas Medicine, Inc. (27)
Eidos Therapeutics, Inc. (13)
Eiger BioPharmaceuticals, Inc. (47)
Elevation Oncology, Inc. (8)
Eliem Therapeutics, Inc. (14)
Emerald Bioscience, Inc. (18)
Emergent BioSolutions Inc. (16)
Enanta Pharmaceuticals, Inc. (26)
Enochian Biosciences Inc (13)
Entasis Therapeutics Holdings Inc. (23)
Entera Bio Ltd. (9)
Entrada Therapeutics, Inc. (9)
Environmental Impact Acquisition Corp (1)
ENZOLYTICS INC (1)
ENZON PHARMACEUTICALS, INC. (22)
Epizyme, Inc. (36)
Equillium, Inc. (10)
Erasca, Inc. (15)
Esperion Therapeutics, Inc. (31)
Evelo Biosciences, Inc. (18)
EVOLUTIONARY GENOMICS, INC. (1)
EXACT SCIENCES CORP (62)
Exelixis (79)
EXICURE, INC. (33)
FATE THERAPEUTICS INC (20)
FENNEC PHARMACEUTICALS INC. (7)
Fibrocell Science, Inc. (30)
FIBROGEN INC (20)
Finch Therapeutics Group, Inc. (13)
FIVE PRIME THERAPEUTICS INC (40)
Flex Pharma, Inc. (29)
Flexion Therapeutics Inc (12)
FLUOROPHARMA MEDICAL, INC. (6)
Foghorn Therapeutics Inc. (14)
Forma Therapeutics Holdings, Inc., (11)
Fortress Biotech, Inc. (15)
Forty Seven, Inc. (8)
Frequency Therapeutics, Inc. (24)
FS Development Corp. (16)
FS Development Corp. II (9)
Fusion Pharmaceuticals Inc. (13)
G1 Therapeutics, Inc. (42)
Gain Therapeutics, Inc. (14)
GALECTIN THERAPEUTICS INC (32)
Galecto Inc. (17)
Galera Therapeutics, Inc. (20)
Gamida Cell Ltd. (22)
Gemphire Therapeutics Inc. (35)
Gene Biotherapeutics, Inc. (6)
GENELUX CORP (13)
Generation Bio Co. (12)
GENEREX BIOTECHNOLOGY CORP (4)
GENETHERA INC (2)
GENOCEA BIOSCIENCES, INC. (20)
Genprex, Inc. (19)
GeoVax Labs, Inc. (28)
GERON CORP (68)
Gilead Sciences (93)
Global Blood Therapeutics, Inc. (25)
GLYCOMIMETICS INC (36)
Gossamer Bio, Inc. (23)
Grail, Inc. (6)
Graphite Bio, Inc. (14)
Greater Cannabis Company, Inc. (2)
Greenwich LifeSciences, Inc. (3)
Gritstone Oncology, Inc. (21)
GT Biopharma, Inc. (29)
GTX INC (73)
GX Acquisition Corp. (28)
HALOZYME THERAPEUTICS INC (14)
HARBOR DIVERSIFIED, INC. (5)
Harpoon Therapeutics, Inc. (16)
HCW Biologics Inc. (8)
Health Sciences Acquisitions Corp (18)
HEAT BIOLOGICS, INC. (58)
HedgePath Pharmaceuticals, Inc. (9)
HEMISPHERX BIOPHARMA INC (19)
HERON THERAPEUTICS, INC. (30)
HilleVax, Inc. (10)
Hillstream BioPharma Inc. (6)
HISTOGENICS CORP (40)
Homology Medicines, Inc. (36)
HOOKIPA Pharma Inc. (14)
HUMANIGEN, INC (29)
iBio, Inc. (15)
Icosavax, Inc. (18)
IDEAYA Biosciences, Inc. (22)
IDERA PHARMACEUTICALS, INC. (65)
IGM Biosciences, Inc. (21)
Imago BioSciences, Inc. (20)
Immix Biopharma, Inc. (6)
IMMUCELL CORP (26)
IMMUNE PHARMACEUTICALS INC (12)
Immune Therapeutics, Inc. (15)
Immuneering Corp (15)
ImmunoCellular Therapeutics, Ltd. (23)
IMMUNOGEN INC (95)
Immunome Inc. (33)
IMMUNOMEDICS INC (34)
IMPEL NEUROPHARMA INC (8)
IN8BIO, INC. (23)
Incyte (38)
INFINITY PHARMACEUTICALS, INC. (25)
Inhibikase Therapeutics, Inc. (13)
Inhibrx, Inc. (26)
InMed Pharmaceuticals Inc. (16)
Inmune Bio, Inc. (10)
Innovation Pharmaceuticals Inc. (9)
INOVIO PHARMACEUTICALS, INC. (33)
Inozyme Pharma, Inc. (27)
INSMED Inc (77)
Inspyr Therapeutics, Inc. (10)
Instil Bio, Inc. (12)
Intec Parent Inc. (9)
Intec Pharma Ltd. (5)
Intellia Therapeutics, Inc. (11)
INTERCEPT PHARMACEUTICALS, INC. (55)
International Stem Cell CORP (4)
INTREXON CORP (26)
Intrinsic Medicine, Inc. (7)
Invitae Corp (37)
IO Biotech, Inc. (1)
IONIS PHARMACEUTICALS INC (14)
IOVANCE BIOTHERAPEUTICS, INC. (39)
IRONWOOD PHARMACEUTICALS INC (37)
Isoray, Inc. (27)
iTeos Therapeutics, Inc. (10)
Janux Therapeutics, Inc. (13)
Jounce Therapeutics, Inc. (14)
Kadmon Holdings, Inc. (18)
KalVista Pharmaceuticals, Inc. (20)
Karuna Therapeutics, Inc. (23)
Karyopharm Therapeutics Inc. (40)
KBL MERGER CORP. IV (38)
Keros Therapeutics, Inc. (17)
Kezar Life Sciences, Inc. (22)
Kindred Biosciences, Inc. (26)
Kiniksa Pharmaceuticals, Ltd. (31)
Kinnate Biopharma Inc. (15)
Kiromic Biopharma, Inc. (26)
KIWA BIO-TECH PRODUCTS GROUP CORP (7)
Kodiak Sciences Inc. (13)
Kronos Bio, Inc. (9)
Krystal Biotech, Inc. (17)
Kura Oncology, Inc. (33)
Kymera Therapeutics, Inc. (7)
LA JOLLA PHARMACEUTICAL CO (24)
Lantern Pharma Inc. (14)
LEAP THERAPEUTICS, INC. (16)
Leisure Acquisition Corp. (12)
LEXICON PHARMACEUTICALS, INC. (37)
LianBio (15)
LifeSci Acquisition Corp. (12)
Ligand Pharmaceuticals Incorporated (13)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (11)
Locust Walk Acquisition Corp. (15)
LogicBio Therapeutics, Inc. (18)
LONGEVERON LLC (8)
Lyell Immunopharma, Inc. (12)
MACROGENICS INC (21)
MADRIGAL PHARMACEUTICALS, INC. (16)
Magenta Therapeutics, Inc. (15)
MAIA Biotechnology, Inc. (18)
MANHATTAN SCIENTIFICS INC (2)
MANNKIND CORP (8)
MARIZYME INC (23)
Marker Therapeutics, Inc. (21)
MATEON THERAPEUTICS INC (62)
Matinas BioPharma Holdings, Inc. (24)
MAXCYTE, INC. (19)
MEDICINOVA INC (35)
Medovex Corp. (13)
MEI Pharma, Inc. (9)
MeiraGTx Holdings plc (23)
MERRIMACK PHARMACEUTICALS INC (30)
Mersana Therapeutics, Inc. (11)
Merus N.V. (8)
Metacrine, Inc. (16)
Millendo Therapeutics, Inc. (54)
MiMedx Group, Inc. (80)
Minerva Neurosciences, Inc. (28)
MiNK Therapeutics, Inc. (13)
MIRAGEN THERAPEUTICS, INC. (59)
Mirati Therapeutics, Inc. (30)
Mirum Pharmaceuticals, Inc. (14)
Moderna, Inc. (18)
Molecular Templates, Inc. (34)
Moleculin Biotech, Inc. (6)
Momenta Pharmaceuticals, Inc. (66)
Monopar Therapeutics (37)
Monte Rosa Therapeutics, Inc. (11)
Morphic Holding, Inc. (13)
MUSTANG BIO, INC. (4)
MYMETICS CORP (2)
Myovant Sciences Ltd. (31)
Myriad Genetics, Inc. (57)
NANOVIRICIDES, INC. (13)
NantKwest, Inc. (9)
Natera, Inc. (18)
NAVIDEA BIOPHARMACEUTICALS, INC. (33)
NEUROBIOLOGICAL TECHNOLOGIES INC (5)
NEUROCRINE BIOSCIENCES INC (20)
NEUROTROPE BIOSCIENCE, INC. (13)
Neurotrope, Inc. (22)
NEWLINK GENETICS CORP (50)
NexImmune, Inc. (17)
NextCure, Inc. (16)
Nkarta, Inc. (17)
NORTHWEST BIOTHERAPEUTICS INC (7)
NOVAVAX INC (50)
Novus Therapeutics, Inc. (25)
NTN BUZZTIME INC (76)
Nuo Therapeutics, Inc. (21)
Nurix Therapeutics, Inc. (10)
Nuvalent, Inc. (9)
Nuvectis Pharma, Inc. (11)
Ohr Pharmaceutical Inc (26)
Olema Pharmaceuticals, Inc. (9)
Olivia Ventures, Inc. (7)
Omega Therapeutics, Inc. (16)
OncBioMune Pharmaceuticals, Inc (13)
OncoCyte Corp (22)
Oncorus, Inc. (13)
ONCOSEC MEDICAL Inc (16)
OPGEN INC (31)
Ophthotech Corp. (24)
Opko Health, Inc. (9)
ORAGENICS INC (24)
Orchard Therapeutics plc (9)
Organicell Regenerative Medicine, Inc. (31)
Organogenesis Holdings Inc. (8)
ORGANOVO HOLDINGS, INC. (36)
Orgenesis Inc. (18)
Oric Pharmaceuticals, Inc. (11)
Outlook Therapeutics, Inc. (20)
Ovid Therapeutics Inc. (25)
Oyster Point Pharma, Inc. (11)
PALATIN TECHNOLOGIES INC (19)
Pasithea Therapeutics Corp. (7)
Passage BIO, Inc. (23)
PDL BIOPHARMA, INC. (40)
PepGen Inc. (9)
Petra Acquisition Inc. (2)
Pfenex Inc. (20)
PharmaCyte Biotech, Inc. (12)
PhaseBio Pharmaceuticals Inc (13)
Phio Pharmaceuticals Corp. (14)
PIERIS PHARMACEUTICALS, INC. (33)
PLURISTEM THERAPEUTICS INC (17)
PMV Pharmaceuticals, Inc. (28)
POLARITYTE, INC. (51)
PORTOLA PHARMACEUTICALS INC (22)
Poseida Therapeutics, Inc. (18)
Praxis Precision Medicines, Inc. (22)
PRECISION BIOSCIENCES INC (28)
PREDICTIVE TECHNOLOGY GROUP, INC. (5)
Prelude Therapeutics Inc (15)
PREMIER BIOMEDICAL INC (3)
Prevail Therapeutics Inc. (8)
Principia Biopharma Inc. (13)
Progenics Pharmaceuticals, Inc. (21)
PROGENITY, INC. (10)
Prometheus Biosciences, Inc. (10)
ProMIS Neurosciences Inc. (4)
Propanc Biopharma, Inc. (7)
Protagenic Therapeutics, Inc. (26)
Protagonist Therapeutics, Inc (13)
Protalix BioTherapeutics, Inc. (14)
PROTEON THERAPEUTICS INC (29)
PROTEOSTASIS THERAPEUTICS, INC. (27)
Prothena Corp plc (37)
ProtoKinetix, Inc. (20)
PTC THERAPEUTICS, INC. (41)
PUMA BIOTECHNOLOGY, INC. (19)
Pyxis Oncology, Inc. (8)
Q BioMed Inc. (2)
Qrons Inc. (2)
Radius Health, Inc. (52)
Rallybio Corp (10)
RAPT Therapeutics, Inc. (9)
Rasna Therapeutics Inc. (1)
RECURSION PHARMACEUTICALS, INC. (12)
Regeneron Pharmaceuticals (47)
REGENERX BIOPHARMACEUTICALS INC (18)
REGENXBIO Inc. (16)
Regulus Therapeutics Inc. (24)
Relay Therapeutics, Inc. (9)
Reneo Pharmaceuticals, Inc. (23)
RenovaCare, Inc. (17)
RenovoRx, Inc. (24)
Repare Therapeutics Inc. (9)
Replimune Group, Inc. (19)
Retrophin, Inc. (38)
Revolution Medicines, Inc. (16)
REXAHN PHARMACEUTICALS, INC. (49)
Rezolute, Inc. (16)
RHYTHM PHARMACEUTICALS, INC. (20)
Rich Pharmaceuticals, Inc. (3)
RIGEL PHARMACEUTICALS INC (51)
RITTER PHARMACEUTICALS INC (27)
ROCKET PHARMACEUTICALS, INC. (15)
Rubius Therapeutics, Inc. (14)
Sage Therapeutics, Inc. (23)
Sana Biotechnology, Inc. (25)
SANGAMO THERAPEUTICS, INC (28)
SANGUI BIOTECH INTERNATIONAL INC (1)
Sarepta Therapeutics, Inc. (78)
Savara Inc (73)
Scholar Rock Holding Corp (13)
SEATTLE GENETICS INC (118)
SELECTA BIOSCIENCES INC (40)
SELLAS Life Sciences Group, Inc. (52)
Sensei Biotherapeutics, Inc. (17)
SERA PROGNOSTICS, INC. (30)
Seres Therapeutics, Inc. (46)
Sesen Bio, Inc. (32)
Shattuck Labs, Inc. (19)
Shuttle Pharmaceuticals Holdings, Inc. (10)
Sierra Oncology, Inc. (11)
Sigilon Therapeutics, Inc. (17)
Silverback Therapeutics, Inc. (19)
Social Capital Suvretta Holdings Corp. III (6)
SOLENO THERAPEUTICS INC (18)
Solid Biosciences Inc. (49)
SOLIGENIX, INC. (25)
SOPHIRIS BIO INC. (5)
Sorrento Therapeutics, Inc. (18)
Spectrum Pharmaceuticals, Inc. (34)
Spero Therapeutics, Inc. (43)
SPHERIX INC (25)
Spinning Eagle Acquisition Corp. (2)
Spring Bank Pharmaceuticals, Inc. (26)
SpringWorks Therapeutics, Inc. (23)
SPRUCE BIOSCIENCES, INC. (20)
SQZ Biotechnologies Co (25)
Stellar Biotechnologies, Inc. (18)
Stoke Therapeutics, Inc. (17)
Summit Therapeutics Inc. (3)
Sun BioPharma, Inc. (27)
SUNESIS PHARMACEUTICALS INC (66)
Sunshine Biopharma, Inc (2)
Surface Oncology, Inc. (18)
SUTRO BIOPHARMA, INC. (6)
Syndax Pharmaceuticals Inc (41)
SYNLOGIC, INC. (37)
Synthetic Biologics, Inc. (30)
Syros Pharmaceuticals, Inc. (13)
T2 Biosystems, Inc. (38)
Talaris Therapeutics, Inc. (13)
Taysha Gene Therapies, Inc. (8)
TCR2 THERAPEUTICS INC. (3)
TENAX THERAPEUTICS, INC. (38)
Tenaya Therapeutics, Inc. (13)
TG THERAPEUTICS, INC. (11)
Therapeutics Acquisition Corp. (21)
Tocagen Inc (25)
Tonix Pharmaceuticals Holding Corp. (20)
Tracon Pharmaceuticals, Inc. (34)
Transcode Therapeutics, Inc. (6)
Translate Bio, Inc. (24)
TREVENA INC (44)
Trovagene, Inc. (16)
TScan Therapeutics, Inc. (14)
Turning Point Therapeutics, Inc. (26)
Twist Bioscience Corp (9)
TYME TECHNOLOGIES, INC. (7)
Tyra Biosciences, Inc. (20)
U.S. Stem Cell, Inc. (8)
Ultragenyx Pharmaceutical Inc. (27)
Unicycive Therapeutics, Inc. (5)
uniQure N.V. (35)
United Therapeutics Corp (37)
Unity Biotechnology, Inc. (29)
Unum Therapeutics Inc. (26)
UroGen Pharma Ltd. (27)
USA EQUITIES CORP. (2)
VACCINEX, INC. (6)
Vaccitech plc (3)
Vanda Pharmaceuticals Inc. (33)
Vaxart, Inc. (31)
Vaxcyte, Inc. (11)
Vaxxinity, Inc. (4)
VBI Vaccines Inc (14)
Vera Therapeutics, Inc. (11)
VERACYTE, INC. (35)
Verastem, Inc. (44)
Vericel Corp (66)
Vertex Pharmaceuticals Inc (48)
Verve Therapeutics, Inc. (18)
VICAL INC (51)
Vicapsys Life Sciences, Inc. (1)
Viela Bio, Inc. (10)
Vigil Neuroscience, Inc. (7)
Viking Therapeutics, Inc. (27)
Vir Biotechnology, Inc. (21)
Virios Therapeutics, LLC (7)
VistaGen Therapeutics, Inc. (17)
VITAL THERAPIES INC (30)
VITRO DIAGNOSTICS INC (13)
Vor Biopharma Inc. (5)
Voyager Therapeutics, Inc. (39)
vTv Therapeutics Inc. (16)
Werewolf Therapeutics, Inc. (15)
WINDTREE THERAPEUTICS INC (50)
XBiotech Inc. (8)
Xencor Inc (30)
Xenetic Biosciences, Inc. (6)
Xenon Pharmaceuticals Inc. (23)
Xilio Therapeutics, Inc. (18)
XOMA Corp (52)
Y-mAbs Therapeutics, Inc. (20)
YIELD10 BIOSCIENCE, INC. (23)
Yulong Eco-Materials Ltd (3)
ZAFGEN, INC. (27)
Zai Lab Ltd (7)
Zentalis Pharmaceuticals, LLC (32)
ZIOPHARM ONCOLOGY INC (49)
Zymeworks Inc. (10)

Recent Contracts

Amended and Restated Non-Employee Director Compensation Policy (Vigil Neuroscience, Inc., Filed With SEC on May 7, 2024)
Amended and Restated Beam Therapeutics Inc. Non-Employee Director Compensation Policy (Beam Therapeutics Inc., Filed With SEC on May 7, 2024)
Amended and Restated Non-Employee Director Compensation Policy, effective April 26, 2024 (Y-mAbs Therapeutics, Inc., Filed With SEC on May 7, 2024)
Severance Agreement dated March 21, 2024 between Y-mAbs Therapeutics A/S and Steen Lisby (Y-mAbs Therapeutics, Inc., Filed With SEC on May 7, 2024)
Summary of Non-Employee Director Compensation Policy (Inozyme Pharma, Inc., Filed With SEC on May 7, 2024)
Rhythm Pharmaceuticals, Inc. 2017 Equity Incentive Plan Performance Unit Agreement (RHYTHM PHARMACEUTICALS, INC., Filed With SEC on May 7, 2024)
Summary of Non-Employee Director Compensation Policy (RHYTHM PHARMACEUTICALS, INC., Filed With SEC on May 7, 2024)
Employment Agreement, dated as of February 2, 2024 by and between Corvus Pharmaceuticals, Inc. and Jeffrey S. Arcara (Corvus Pharmaceuticals, Inc., Filed With SEC on May 7, 2024)
Supplemental Compensation Recovery Policy (MADRIGAL PHARMACEUTICALS, INC., Filed With SEC on May 7, 2024)
Non-Employee Director Compensation Policy, as amended, dated April 22, 2024 (FIBROGEN INC, Filed With SEC on May 6, 2024)
Termination and Transition Agreement to Development and Commercialization Agreement (for the U.S. and Certain Other Territories), by and between AstraZeneca AB and FibroGen, Inc.,... (FIBROGEN INC, Filed With SEC on May 6, 2024)
Omega Therapeutics, Inc. 2021 Incentive Award Plan Stock Option Grant Notice and Stock Option Agreement issued to Mahesh Karande on February 7, 2024 (Omega Therapeutics, Inc., Filed With SEC on May 6, 2024)
Amended and Restated Outside Director Compensation Policy (Oric Pharmaceuticals, Inc., Filed With SEC on May 6, 2024)
Non-Employee Director Compensation Program, as amended (Retrophin, Inc., Filed With SEC on May 6, 2024)
Amended Employment Agreement with Barry Ginsberg dated September 14, 2023 (Curative Biotechnology Inc, Filed With SEC on May 6, 2024)
Amended Employment Agreement with Paul Michaels dated February 28, 2024 (Curative Biotechnology Inc, Filed With SEC on May 6, 2024)
Amended Employment Agreement with Paul Michaels dated September 14, 2023 (Curative Biotechnology Inc, Filed With SEC on May 6, 2024)
Amended Employment Agreement with Richard Garr dated September 14, 2023 (Curative Biotechnology Inc, Filed With SEC on May 6, 2024)
Form of Restricted Stock Unit Agreement under 2024 Inducement Stock Incentive Plan (Dyne Therapeutics, Inc., Filed With SEC on May 2, 2024)
Form of Nonstatuory Stock Option Agreement under 2024 Inducement Stock Incentive Plan (Dyne Therapeutics, Inc., Filed With SEC on May 2, 2024)
Amended and Restated Non-Employee Director Compensation Policy dated March 27, 2024 (Kymera Therapeutics, Inc., Filed With SEC on May 2, 2024)
Amendment to Employment Agreement dated March 2 (Twist Bioscience Corp, Filed With SEC on May 2, 2024)
Retention Bonus, effective as of January 25, 2024, by and between Registrant and Jacqueline Zummo, Ph.D, MPH, MBA (PROTEON THERAPEUTICS INC, Filed With SEC on May 2, 2024)
Amended and Restated Non-Employee Director Compensation Policy (PROTEON THERAPEUTICS INC, Filed With SEC on May 2, 2024)
Form of Stock Option Grant Notice and Option Agreement for grants made to Kevin Gorman on or after February 13, 2024 made under the Neurocrine Biosciences, Inc. 2020 Equity... (NEUROCRINE BIOSCIENCES INC, Filed With SEC on May 1, 2024)
Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement for grants on or after February 13, 2024 made under the Neurocrine Biosciences, Inc.... (NEUROCRINE BIOSCIENCES INC, Filed With SEC on May 1, 2024)
Amended and Restated Executive Employment Agreement dated April 29, 2024 between the Company and Mr. Fletcher Payne (Aptose Biosciences Inc., Filed With SEC on May 1, 2024)
Amended and Restated Executive Employment Agreement dated April 29, 2024 between the Company and Dr. Rafael Bejar (Aptose Biosciences Inc., Filed With SEC on May 1, 2024)
Second Amended and Restated Executive Employment Agreement dated April 29, 2024 between the Company and Dr. William G. Rice (Aptose Biosciences Inc., Filed With SEC on May 1, 2024)
Form of Restricted Stock Unit Award Agreement under Sarepta Therapeutics, Inc. 2024 Employment Commencement Incentive Plan (Sarepta Therapeutics, Inc., Filed With SEC on May 1, 2024)
Form of Stock Option Award Agreement under Sarepta Therapeutics, Inc. 2024 Employment Commencement Incentive Plan (Sarepta Therapeutics, Inc., Filed With SEC on May 1, 2024)
Amended Employment Agreement, dated October 31, 2023 by and between Summit Therapeutics Inc. and Mahkam Zanganeh (Summit Therapeutics Inc., Filed With SEC on May 1, 2024)
First Amendment to Employment Agreement by and between Monica R. Thomas and the Registrant effective as of April 1, 2024 (G1 Therapeutics, Inc., Filed With SEC on May 1, 2024)
Second Amendment to Employment Agreement by and between Terry Murdock and the Registrant effective as of April 1, 2024 (G1 Therapeutics, Inc., Filed With SEC on May 1, 2024)
Third Amendment to Employment Agreement by and between Rajesh Malik and the Registrant effective as of April 1, 2024 (G1 Therapeutics, Inc., Filed With SEC on May 1, 2024)
First Amendment to Employment Agreement by and between Andrew Perry and the Registrant effective as of April 1, 2024 (G1 Therapeutics, Inc., Filed With SEC on May 1, 2024)
Separation Agreement and General Release, dated April 30, 2024, by and between the Company and Henry Hagopian, III (Annovis Bio, Inc., Filed With SEC on May 1, 2024)
Form of Nonqualified Stock Option Agreement under the MiMedx Group, Inc. 2016 Equity and Cash Incentive Plan (MiMedx Group, Inc., Filed With SEC on April 30, 2024)
Form of Performance Stock Unit Agreement under the MiMedx Group, Inc. 2016 Equity and Cash Incentive Plan (MiMedx Group, Inc., Filed With SEC on April 30, 2024)
Form of Restricted Stock Unit Agreement under the MiMedx Group, Inc. 2016 Equity and Cash Incentive Plan (MiMedx Group, Inc., Filed With SEC on April 30, 2024)